⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13398605 | 0.76 | — | — | |
| SCHEMBL3318288 | 0.76 | — | — | |
| SCHEMBL7363814 | 0.72 | — | — | |
| SCHEMBL1761782 | 0.72 | — | — | |
| SCHEMBL15466711 | 0.72 | — | — | |
| SCHEMBL16076273 | 0.71 | — | — | |
| SCHEMBL16076277 | 0.71 | — | — | |
| SCHEMBL7416032 | 0.71 | — | — | |
| SCHEMBL906308 | 0.71 | HSD11B1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL1761547 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | claimed |
| EP-2505588-B1 | process for preparing AMINOMETHYL AZAADAMANTANE DERIVATIVES as SELECTIVE MODULATORS OF THE ALPHA7- NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR (NNRS) | ABBVIE INC (US) | 2013-11-13 | — | — | EP | claimed |
| EP-2505588-A1 | Process for preparing aminomethyl azaadamantane derivatives as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (NNRS) | Abbott Laboratories (US) | 2012-10-03 | — | — | EP | claimed |
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045779-A1 | COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION | XU LIFENG (US) | 2014-02-13 | — | — | US | disclosed |
| EP-2505588-B1 | process for preparing AMINOMETHYL AZAADAMANTANE DERIVATIVES as SELECTIVE MODULATORS OF THE ALPHA7- NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR (NNRS) | ABBVIE INC (US) | 2013-11-13 | — | — | EP | disclosed |
| EP-2505588-A1 | Process for preparing aminomethyl azaadamantane derivatives as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (NNRS) | Abbott Laboratories (US) | 2012-10-03 | — | — | EP | disclosed |
| US-8168791-B2 | N-[(4r)-1-azatricyclo[3.3.1.13,7]dec-4-ylmethyl]-5-chloro-1H-indole-2-carboxamide; disorders or deficits modulated by an alpha 7 nicotinic acetylcholine receptor, an alpha 4 beta 2 nicotinic acetylcholine receptor or both; schizophrenia | ABBOTT LABORATORIES (US) | 2012-05-01 | — | — | US | disclosed |
| US-8168791-B2 | N-[(4r)-1-azatricyclo[3.3.1.13,7]dec-4-ylmethyl]-5-chloro-1H-indole-2-carboxamide; disorders or deficits modulated by an alpha 7 nicotinic acetylcholine receptor, an alpha 4 beta 2 nicotinic acetylcholine receptor or both; schizophrenia | ABBOTT LABORATORIES (US) | 2012-05-01 | — | — | US | disclosed |
| US-8168791-B2 | N-[(4r)-1-azatricyclo[3.3.1.13,7]dec-4-ylmethyl]-5-chloro-1H-indole-2-carboxamide; disorders or deficits modulated by an alpha 7 nicotinic acetylcholine receptor, an alpha 4 beta 2 nicotinic acetylcholine receptor or both; schizophrenia | ABBOTT LABORATORIES (US) | 2012-05-01 | — | — | US | disclosed |
| EP-0652879-B1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT4 AGONISTS OR ANTAGONISTS AND/OR 5-HT3 ANTAGONISTS | SEARLE & CO (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5840903-A | 5-HT3 AND 5-HT4 AGONISTS AND ANTAGONISTS | G. D. SEARLE & CO. (US) | 1998-11-24 | — | — | US | disclosed |
| US-5840903-A | 5-HT3 AND 5-HT4 AGONISTS AND ANTAGONISTS | G. D. SEARLE & CO. (US) | 1998-11-24 | — | — | US | disclosed |
| US-5643917-A | GASTROINTESTINAL DISORDERS, 5HT ANTAGONISTS OR AGONISTS, COGNITION ACTIVATORS OR CNS DISORDERS | G. D. SEARLE & CO. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5643917-A | GASTROINTESTINAL DISORDERS, 5HT ANTAGONISTS OR AGONISTS, COGNITION ACTIVATORS OR CNS DISORDERS | G. D. SEARLE & CO. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5534521-A | SEROTONIN ANTAGONISTS | G. D. SEARLE & CO. (US) | 1996-07-09 | — | — | US | disclosed |
| US-5521193-A | SEROTONIN AGONISTS AND ANTAGONISTS | G. D. SEARLE & CO. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0652879-A1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT AGONISTS OR ANTAGONISTS | G.D. SEARLE & CO. (US) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994002482-A1 | 1-AZAADAMANTANE DERIVATIVES AS 5-HT AGONISTS OR ANTAGONISTS | G.D. SEARLE & CO. (US) | 1994-02-03 | — | — | WO | disclosed |